Diagnostic Accuracy and Reproducibility of WHO-Endorsed Phenotypic Drug Susceptibility Testing Methods for First-Line and Second-Line Antituberculosis Drugs
- 1 February 2013
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 51 (2) , 393-401
Abstract
In an effort to update and clarify policies on tuberculosis drug susceptibility testing (DST), the World Health Organization (WHO) commissioned a systematic review evaluating WHO-endorsed diagnostic tests. We report the results of this systematic review and meta-analysis of the diagnostic accuracy and reproducibility of phenotypic DST for first-line and second-line antituberculosis drugs. This review provides support for recommended critical concentrations for isoniazid and rifampin in commercial broth-based systems. Further studies are needed to evaluate critical concentrations for ethambutol and streptomycin that accurately detect susceptibility to these drugs. Evidence is limited on the performance of DST for pyrazinamide and second-line drugs.Keywords
This publication has 24 references indexed in Scilit:
- QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy StudiesAnnals of Internal Medicine, 2011
- Microscopic-observation drug susceptibility and thin layer agar assays for the detection of drug resistant tuberculosis: a systematic review and meta-analysisThe Lancet Infectious Diseases, 2010
- Multicenter Evaluation of Bactec MGIT 960 System for Second-Line Drug Susceptibility Testing of Mycobacterium tuberculosis ComplexJournal of Clinical Microbiology, 2009
- Direct susceptibility testing for multi drug resistant tuberculosis: A meta-analysisBMC Infectious Diseases, 2009
- A systematic review of rapid drug susceptibility tests for multidrug-resistant tuberculosis using rifampin resistance as a surrogateExpert Opinion on Medical Diagnostics, 2009
- Systematic Reviews of Diagnostic Test AccuracyAnnals of Internal Medicine, 2008
- Inter- and Intra-Assay Reproducibility of Microplate Alamar Blue Assay Results for Isoniazid, Rifampicin, Ethambutol, Streptomycin, Ciprofloxacin, and Capreomycin Drug Susceptibility Testing of Mycobacterium tuberculosisJournal of Clinical Microbiology, 2008
- Colorimetric redox-indicator methods for the rapid detection of multidrug resistance in Mycobacterium tuberculosis: a systematic review and meta-analysisJournal of Antimicrobial Chemotherapy, 2006
- Challenges in Systematic Reviews of Diagnostic TechnologiesAnnals of Internal Medicine, 2005
- Proficiency testing of conventional drug susceptibility tests of Mycobacterium tuberculosisCanadian Journal of Microbiology, 1987